Sepsis

Blood culture contamination remains a persistent challenge in healthcare, impacting patient care and outcomes, and driving up costs. As awareness grows, blood culture kitting has emerged as a practical solution to improve sample collection by standardizing supplies, simplifying decision-making, and reducing waste.

When antimicrobial resistance (AMR) and sepsis collide, the stakes for patient survival become even more critical.

When antimicrobial resistance (AMR) and sepsis collide, the stakes for patient survival become even more critical.

A recent survey by bioMérieux and The UK Sepsis Trust found that while 95% of clinicians identify sepsis as a serious condition, 66% agree there is sometimes a delay in diagnosis in the hospital where they work. 

A recent retrospective study examining sepsis treatment in patients with and without pulmonary arterial hypertension (PAH) reveals critical insights for clinical practice.

Play MICROBE LEAP, bioMérieux’s interactive AMS game, to test your diagnostic knowledge and antimicrobial stewardship skills as a Patient Protector or Resistance Avenger!

Play MICROBE LEAP, bioMérieux’s interactive AMS game, to test your diagnostic knowledge and antimicrobial stewardship skills as a Patient Protector or Resistance Avenger!

Play MICROBE LEAP, bioMérieux’s interactive AMS game, to test your diagnostic knowledge and antimicrobial stewardship skills as a Patient Protector or Resistance Avenger!

Delve into the critical challenges of sepsis management in resource-limited settings with Professor Machado's insightful interview.

This series covers advances in diagnostic and antimicrobial stewardship, focusing on multiplex PCR testing to combat MDROs and improve prescribing.

A study shows source-specific antibiotic order sets in emergency care improve empiric treatment decisions for sepsis and support timely patient management.

The Sepsis Alliance AMR Virtual Conference explores innovative solutions and educational initiatives for managing sepsis and combating antimicrobial resistance.

Explore key insights from ID pharmacists on antimicrobial stewardship challenges, survey findings, and strategies for improving ASP implementation.

A study from The University of Manchester highlights how socioeconomic factors increase mortality risk in non-COVID sepsis, stressing targeted prevention.

The BIOFIRE® BCID2 Panel uses rapid PCR technology to identify pathogens and resistance genes, improving antimicrobial stewardship, patient outcomes, and reducing hospital stay.

EHR-based data shows SARS-CoV-2–associated sepsis was more severe and frequent than bacterial sepsis early in the pandemic, highlighting tracking gaps.

A new study with the UK Sepsis Trust explores barriers to sepsis care bundle adherence in Europe and offers insights to improve sepsis management strategies.

The Sepsis Alliance AMR Virtual Conference explores solutions for combating antimicrobial resistance and improving sepsis outcomes.

Rapid diagnostics and antimicrobial stewardship are key to optimizing sepsis outcomes by enabling timely, targeted testing and treatment decisions.

A study in Cameroon highlights rising sepsis cases and AMR, emphasizing the need for surveillance, infection control, and antibiotic stewardship in hospitals.

A clinical trial in West Africa tests whether intrapartum azithromycin reduces neonatal sepsis and mortality, with additional evaluation of infection and fever rates.

Innovative space planning is essential for lab safety, efficiency, and success, ensuring productivity and improved diagnostic outcomes

Superbugs are worsening neonatal sepsis outcomes in South Asia where antibiotic resistance is driving high mortality rates in newborns with severe infections.

Explore the comparison of clinical sepsis phenotypes in critically ill COVID-19 patients and implications for predicting outcomes, treatment, and personalized medicine.

Explore the impact of neonatal sepsis and Group B Strep, and learn about global recommendations for prevention and care.

The SepSIGN trial aims to validate biomarkers that help predict early clinical worsening in adults admitted to the ED with suspected or confirmed infection.

Biomarkers and syndromic testing help mitigate risks of AKI, AMR, and sepsis, aiding healthcare providers in improving patient care and outcomes.

A PCT-based sepsis protocol in ICU patients cut antibiotic use and saved $1,200+ per patient without affecting mortality, per a study by Dr. Jarva Chow.

Sepsis linked to opioid use is an overlooked crisis driving hospitalizations and harm, with experts urging strategies to address this growing public health issue.

The Surviving Sepsis Campaign infographic highlights updated global guidelines on antibiotic timing, vasoactive agents, and septic shock care.

Balancing timely sepsis treatment with AKI risk, experts highlight how early biomarker assessment can guide safer, more effective antimicrobial use.

September is Sepsis Awareness Month, with resources and tools to help individuals and healthcare teams raise awareness and improve patient outcomes.

See the CDC white paper on advancing diagnostic stewardship to improve patient safety in healthcare-associated infections, antibiotic resistance, and sepsis.

A systematic review shows COVID-19 ICU patients often meet sepsis criteria, highlighting the need for targeted treatments and policies for future pandemics.

Research at Massachusetts General Hospital reveals how severe COVID-19 linked to sepsis shows higher activity of MS1 cells

With 15 sessions and 90 speakers from around the globe, the 2021 World Sepsis Congress covered relevent and timely issues that affect sepsis research and patient care. 

This infographic breaks down the medical and economic toll of sepsis, offering key data to support greater awareness and informed healthcare discussions.

A podcast explores how new CAP guidelines view procalcitonin use alongside clinical judgment to guide antibiotic decisions in sepsis and respiratory care.